Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05726786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Study acronym: INCyst
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 9, 2025 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 3 to 4
    • Collaborators: 2 to 3
    v5
  2. Start date changed from estimate of Apr 2023 to Apr 10, 2023v4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jul 2026 to Aug 2026
    • Study completion date: Sep 2026 to Oct 2026
    • Start date: Mar 2023 to Apr 2023
    • Site details revised at 3 of 3 sites
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial research study is to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing a cystectomy. As a secondary focus, this study will aim to develop a signature that would identify patients that would benefit the most from IN. This is a multicentric (Swiss: N=3), prospective, controlled, pragmatic, parallel-group comparative study with block randomization stratified by centers.
Trial Details
NCT Number NCT05726786
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Collaborators: Insel Gruppe AG, University Hospital Bern, Hôpital Riviera-Chablais, Vaud-Valais, University Hospital, Geneva
Conditions
(from sponsor)		 Bladder Cancer, Interstitial Cystitis, Painful Bladder Syndrome, Neurogenic Bladder, Hemorrhagic Cystitis, Endometriosis, Bladder Disease
Related terms Cystitis, Hemorrhagic, Cystitis, Interstitial, Endometriosis, Malnutrition, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic
Enrollment 232 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov